Vaccitech CMO Dr. Margaret Marshall retires effective July 20, 2023; consulting agreement with continued equity vesting

Barinthus Biotherapeutics plc.

Dr. Margaret Marshall retired as Chief Medical Officer of Vaccitech effective July 20, 2023.
She will enter into a consulting agreement with the company for continued services.
Certain of her equity interests will continue to vest for a nine-month period.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dr. Margaret Marshall

Chief Medical Officer

BRNS · Barinthus Biotherapeutics plc.

Effective: 2023-07-20
Filed: July 26, 2023, 7:59 PM ET

On July 20, 2023, Dr. Margaret Marshall notified Vaccitech plc (the “Company”) of her intention to retire from her position as Chief Medical Officer of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Margaret Marshall retired as Chief Medical Officer at Barinthus Biotherapeutics plc..

Action: retired
Role: Chief Medical Officer

Exact text from the filing

On July 20, 2023, Dr. Margaret Marshall notified Vaccitech plc (the “Company”) of her intention to retire from her position as Chief Medical Officer of the Company, effective immediately.

View on SEC.gov

Barinthus Biotherapeutics plc. filing history →

Source: SEC EDGAR

accession 0001104659-23-084289

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.